Target Price | $160.57 |
Price | $148.41 |
Potential |
8.19%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target Cardinal Health 2026 .
The average Cardinal Health target price is $160.57.
This is
8.19%
register free of charge
$173.00
16.57%
register free of charge
$136.00
8.36%
register free of charge
|
|
A rating was issued by 18 analysts: 13 Analysts recommend Cardinal Health to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Cardinal Health stock has an average upside potential 2026 of
8.19%
register free of charge
|
Jun '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 226.83 | 223.25 |
10.66% | 1.58% | |
EBITDA Margin | 1.26% | 1.43% |
4.36% | 13.29% | |
Net Margin | 0.36% | 0.75% |
147.43% | 106.32% |
14 Analysts have issued a sales forecast Cardinal Health 2025 . The average Cardinal Health sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Cardinal Health EBITDA forecast 2025. The average Cardinal Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Cardinal Health Analysts have issued a net profit forecast 2025. The average Cardinal Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.45 | 6.98 |
173.81% | 102.32% | |
P/E | 21.27 | |
EV/Sales | 0.18 |
5 Analysts have issued a Cardinal Health forecast for earnings per share. The average Cardinal Health EPS is
This results in the following potential growth metrics and future valuations:
Cardinal Health...
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Locked
➜
Locked
|
Locked | May 05 2025 |
Baird |
Locked
➜
Locked
|
Locked | May 02 2025 |
UBS |
Locked
➜
Locked
|
Locked | May 02 2025 |
UBS |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
Jefferies |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
Analyst Rating | Date |
---|---|
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 05 2025 |
Locked
Baird:
Locked
➜
Locked
|
May 02 2025 |
Locked
UBS:
Locked
➜
Locked
|
May 02 2025 |
Locked
UBS:
Locked
➜
Locked
|
Apr 29 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Apr 11 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
Jefferies:
Locked
➜
Locked
|
Feb 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.